1X10^6 human PBMCs were surface co-stained with FITC Anti-Human CD3 and 0.2 ug Anti-Human CD16 (65090-1-Ig, Clone:3G8) and APC-Goat anti-Mouse IgG at dilution 1:1000. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 0.2 ug Anti-Human CD16 (65090-1-Ig, Clone:3G8) and APC-Goat anti-Mouse IgG at dilution 1:1000. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with PE Anti-Human CD3 and 5 ul APC Anti-Human CD16 (APC-65090, Clone:3G8) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with PE Anti-Human CD3 and 5 ul APC Anti-Human CD16 (APC-65090, Clone:3G8) or Mouse IgG1 Isotype Control. Cells were not fixed. CD3- lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with PE Anti-Human CD3 and 5 ul Atlantic Blue™ Anti-Human CD16 (AB-65090, Clone:3G8) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with PE Anti-Human CD3 and 5 ul Atlantic Blue™ Anti-Human CD16 (AB-65090, Clone:3G8) or Mouse IgG1 Isotype Control. Cells were not fixed. CD3 negative lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with Atlantic Blue Anti-Human CD3 and 5 ul Cardinal Red™ Anti-Human CD16 (CR-65090, Clone:3G8) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with Atlantic Blue Anti-Human CD3 and 5 ul Cardinal Red™ Anti-Human CD16 (CR-65090, Clone:3G8) (red) or Mouse IgG1 Isotype Control. Cells were not fixed. CD3 negative lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with PE Anti-Human CD3 and 5 ul CoraLite®405 Anti-Human CD16 (CL405-65090, Clone:3G8) or Mouse IgG1 Isotype Control. Cells were not fixed. CD3- lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with PE Anti-Human CD3 and 5 ul CoraLite®405 Anti-Human CD16 (CL405-65090, Clone:3G8) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with CL750 Anti-Human CD3 and 5 ul CoraLite® Plus 488 Anti-Human CD16 (CL488-65090, Clone:3G8), or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 488 Anti-Human CD16 (CL488-65090, Clone:3G8), or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with CL647 Anti-Human CD3 and 5 ul CoraLite® Plus 555 Anti-Human CD16 (CL555-65090, Clone:3G8) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with PE Anti-Human CD3 and 5 ul CoraLite® Plus 647 Anti-Human CD16 (CL647-65090, Clone: 3G8) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.

---

1X10^6 human PBMCs were surface co-stained with PE Anti-Human CD3 and 5 ul CoraLite® Plus 647 Anti-Human CD16 (CL647-65090, Clone: 3G8) or Mouse IgG1 Isotype Control. Cells were not fixed. CD3-negative lymphocytes were gated.

---